Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| PTK2B | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence |
|
||||
| PTK2B | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 268.0 | Evidence | |||||
| PTK2B | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 268.0 | Evidence |
|
||||
| PTK2B | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 268.0 | Evidence |
|
||||
| PTK2B | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 268.0 | Evidence | |||||
| PTK2B | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 200.0 | Evidence | |||||
| PTK2B | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 200.0 | Evidence | |||||
| PTK2B | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 156.0 | Evidence |
|
||||
| PTK2B | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 139.0 | Evidence | |||||
| PTK2B | SYK | SYK: Tyrosine-protein kinase SYK | 139.0 | Evidence |
|
||||
| PTK2B | CRKL | CRKL: Crk-like protein | 139.0 | Evidence | |||||
| PTK2B | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 125.0 | Evidence | |||||
| PTK2B | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 121.0 | Evidence |
|
||||
| PTK2B | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| PTK2B | LNK | SH2B3, LNK: SH2B adapter protein 3 | 119.0 | Evidence | |||||
| PTK2B | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 119.0 | Evidence |
|
||||
| PTK2B | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 119.0 | Evidence | |||||
| PTK2B | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 119.0 | Evidence |
|
||||
| PTK2B | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 119.0 | Evidence | |||||
| PTK2B | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 119.0 | Evidence | |||||
| PTK2B | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 119.0 | Evidence | |||||
| PTK2B | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 119.0 | Evidence | |||||
| PTK2B | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 119.0 | Evidence | |||||
| PTK2B | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 117.0 | Evidence | |||||
| PTK2B | HCK | N/A | 106.0 | Evidence | |||||
| PTK2B | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 106.0 | Evidence | |||||
| PTK2B | CSK | CSK: Tyrosine-protein kinase CSK | 106.0 | Evidence | |||||
| PTK2B | APS | SH2B2, APS: SH2B adapter protein 2 | 106.0 | Evidence | |||||
| PTK2B | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 106.0 | Evidence | |||||
| PTK2B | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| PTK2B | JAK1 | 106.0 | Evidence |
|
|||||
| PTK2B | STAT3 | 106.0 | Evidence |
|
|||||
| PTK2B | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 106.0 | Evidence | |||||
| PTK2B | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 106.0 | Evidence |
|
||||
| PTK2B | VAV1 | VAV1, VAV: Proto-oncogene vav | 106.0 | Evidence |
|
||||
| PTK2B | LYN | LYN: Tyrosine-protein kinase Lyn | 106.0 | Evidence |
|
||||
| PTK2B | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 106.0 | Evidence | |||||
| PTK2B | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 106.0 | Evidence | |||||
| PTK2B | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 106.0 | Evidence |
|
||||
| PTK2B | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 104.0 | Evidence | |||||
| PTK2B | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 89.20 | Evidence | |||||
| PTK2B | GRB10 | N/A | 56.20 | Evidence | |||||
| PTK2B | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 32.90 | Evidence | |||||
| PTK2B | GRAP | GRAP: GRB2-related adapter protein | 32.90 | Evidence | |||||
| PTK2B | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 31.60 | Evidence | |||||
| PTK2B | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 22.30 | Evidence |
|
||||
| PTK2B | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 22.30 | Evidence | |||||
| PTK2B | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 22.30 | Evidence | |||||
| PTK2B | KIT | KIT: Mast/stem cell growth factor receptor precursor | 22.30 | Evidence | |||||
| PTK2B | SHB | SHB: SH2 domain-containing adapter protein B | 21.50 | Evidence | |||||
| PTK2B | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 21.50 | Evidence | |||||
| PTK2B | STAM2 | STAM2: Signal transducing adapter molecule 2 | 20.50 | Evidence | |||||
| PTK2B | IRS2 | IRS2: Insulin receptor substrate 2 | 15.00 | Evidence | |||||
| PTK2B | CTTN | CTTN, EMS1: Src substrate cortactin | 15.00 | Evidence | |||||
| PTK2B | IRS1 | IRS1: Insulin receptor substrate 1 | 15.00 | Evidence | |||||
| PTK2B | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 14.10 | Evidence | |||||
| PTK2B | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 13.50 | Evidence |
|
||||
| PTK2B | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 13.50 | Evidence |
|
||||
| PTK2B | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 13.50 | Evidence | |||||
| PTK2B | INSR | INSR: Insulin receptor precursor | 13.50 | Evidence | |||||
| PTK2B | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.40 | Evidence | |||||
| PTK2B | DOK1 | DOK1: Docking protein 1 | 13.40 | Evidence | |||||
| PTK2B | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 13.40 | Evidence | |||||
| PTK2B | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 13.40 | Evidence | |||||
| PTK2B | CD2AP | CD2AP: CD2-associated protein | 13.40 | Evidence | |||||
| PTK2B | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 11.60 | Evidence |
|
||||
| PTK2B | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 11.60 | Evidence | |||||
| PTK2B | ACTG1 | ACTB: Actin, cytoplasmic 1 | 10.30 | Evidence | |||||
| PTK2B | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 10.30 | Evidence | |||||
| PTK2B | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 9.92 | Evidence | |||||
| PTK2B | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 9.92 | Evidence | |||||
| PTK2B | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence | |||||
| PTK2B | EPOR | EPOR: Erythropoietin receptor precursor | 9.92 | Evidence | |||||
| PTK2B | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 9.92 | Evidence | |||||
| PTK2B | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 9.92 | Evidence | |||||
| PTK2B | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 9.92 | Evidence | |||||
| PTK2B | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 9.92 | Evidence | |||||
| PTK2B | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 9.92 | Evidence | |||||
| PTK2B | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 9.92 | Evidence | |||||
| PTK2B | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 9.92 | Evidence | |||||
| PTK2B | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 9.92 | Evidence | |||||
| PTK2B | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
| PTK2B | ITGB4 | N/A | 9.92 | Evidence | |||||
| PTK2B | GHR | GHR: Growth hormone receptor precursor | 9.92 | Evidence | |||||
| PTK2B | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 9.92 | Evidence | |||||
| PTK2B | MET | MET: Hepatocyte growth factor receptor precursor | 9.92 | Evidence | |||||
| PTK2B | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 9.92 | Evidence | |||||
| PTK2B | SOS1 | SOS1: Son of sevenless homolog 1 | 8.89 | Evidence | |||||
| PTK2B | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 8.89 | Evidence | |||||
| PTK2B | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 8.89 | Evidence | |||||
| PTK2B | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 8.89 | Evidence | |||||
| PTK2B | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 8.89 | Evidence | |||||
| PTK2B | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 8.89 | Evidence | |||||
| PTK2B | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 8.89 | Evidence | |||||
| PTK2B | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 8.89 | Evidence | |||||
| PTK2B | EFNB1 | EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor | 8.55 | Evidence | |||||
| PTK2B | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 7.59 | Evidence | |||||
| PTK2B | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 6.80 | Evidence | |||||
| PTK2B | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 6.80 | Evidence | |||||
| PTK2B | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 6.80 | Evidence | |||||
| PTK2B | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence |
|
||||
| PTK2B | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 4.68 | Evidence | |||||
| PTK2B | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 4.68 | Evidence | |||||
| PTK2B | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 4.48 | Evidence | |||||
| PTK2B | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 4.48 | Evidence | |||||
| PTK2B | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 4.48 | Evidence | |||||
| PTK2B | LAT | LAT: Linker for activation of T-cells family member 1 | 4.48 | Evidence | |||||
| PTK2B | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 4.19 | Evidence | |||||
| PTK2B | RAN | RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran | 3.47 | Evidence | |||||
| PTK2B | EFNA1 | EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor | 3.02 | Evidence | |||||